semaglutide prediabetes progression to diabetes trial for Prediabetes: A Guide Preventing Type 2 Semaglutide phase 3 SUSTAIN trials

These results indicate that SOCS3 represents a transcriptional inhibitor of preproinsulin gene expression, which is induced by leptin via JAK-STAT3/5b signaling in pancreatic -cells (Laubner et al., 2005)

This is one of the earliest visible signs of inadequate protein and is commonly reported in the GLP-1 hair loss literature

22 , e20889 (2020)

Oral melanotic macule (MM) is a small, well-circumscribed, brown-to-black macule, and about of 665 cases has been reported in the English literature (2)

Rare exceptions may exist when a procedure addresses a documented medical necessity such as lipedema

Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications